Research ArticleNEUROPHARMACOLOGY
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
Prisca Honore, Diana Donnelly-Roberts, Marian T. Namovic, Gin Hsieh, Chang Z. Zhu, Joe P. Mikusa, Gricelda Hernandez, Chengmin Zhong, Donna M. Gauvin, Prasant Chandran, Richard Harris, Arturo Perez Medrano, William Carroll, Kennan Marsh, James P. Sullivan, Connie R. Faltynek and Michael F. Jarvis
Journal of Pharmacology and Experimental Therapeutics December 2006, 319 (3) 1376-1385; DOI: https://doi.org/10.1124/jpet.106.111559
Prisca Honore
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Diana Donnelly-Roberts
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Marian T. Namovic
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Gin Hsieh
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Chang Z. Zhu
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Joe P. Mikusa
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Gricelda Hernandez
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Chengmin Zhong
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Donna M. Gauvin
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Prasant Chandran
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Richard Harris
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Arturo Perez Medrano
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
William Carroll
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Kennan Marsh
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
James P. Sullivan
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Connie R. Faltynek
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Michael F. Jarvis
Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNEUROPHARMACOLOGY
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
Prisca Honore, Diana Donnelly-Roberts, Marian T. Namovic, Gin Hsieh, Chang Z. Zhu, Joe P. Mikusa, Gricelda Hernandez, Chengmin Zhong, Donna M. Gauvin, Prasant Chandran, Richard Harris, Arturo Perez Medrano, William Carroll, Kennan Marsh, James P. Sullivan, Connie R. Faltynek and Michael F. Jarvis
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1376-1385; DOI: https://doi.org/10.1124/jpet.106.111559
Research ArticleNEUROPHARMACOLOGY
A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat
Prisca Honore, Diana Donnelly-Roberts, Marian T. Namovic, Gin Hsieh, Chang Z. Zhu, Joe P. Mikusa, Gricelda Hernandez, Chengmin Zhong, Donna M. Gauvin, Prasant Chandran, Richard Harris, Arturo Perez Medrano, William Carroll, Kennan Marsh, James P. Sullivan, Connie R. Faltynek and Michael F. Jarvis
Journal of Pharmacology and Experimental Therapeutics December 1, 2006, 319 (3) 1376-1385; DOI: https://doi.org/10.1124/jpet.106.111559
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement